Hotspur spurred on by FDA clearance of dialysis devices
This article was originally published in Clinica
Hotspur Technologies has received US FDA 510(k) clearance for its first three products. The IQCath and GPSCath balloon dilatation catheter, and the Keeper embolectomy catheter, are designed to improve dialysis access and procedures to open blocked blood vessels in the arms and legs.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.